Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease

Figure 7 Microbiota characteristics of healthy controls and different liver disease groups: Linear discriminant analysis effect size analysis reveals significant differential biomarkers. A and B: Linear discriminant analysis effect size (LEfSe) analysis between the chronic hepatitis B group and the healthy control group. The primary objective of LEfSe analysis is to compare two or more groups and identify marker species that exhibit statistically significant differences in abundance across the taxonomic levels of phylum, class, order, family, genus, and species; C and D: LEfSe analysis between the cirrhosis group and the healthy control group; E and F: LEfSe analysis between the hepatocellular carcinoma group and the healthy control group. LAD: Linear discriminant analysis; ZC: Healthy control group; HZ: Chronic hepatitis B group; LC: Liver cirrhosis; HCC: Hepatocellular carcinoma.